In Vitro Methods for Analyzing miRNA Roles in Cancer Cell Proliferation, Invasion, and Metastasis

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1733)

Abstract

MicroRNAs (miRNAs) are small noncoding, single-stranded RNAs consisting of 20–24 nucleotides (Bartel, Cell 116:281–297, 2004), which regulate target genes expression by interacting with 3′-untranslated regions (3′-UTRs) of target mRNAs, leading to translation repression or mRNA degradation (Filipowicz et al., Nat Rev Genet 9:102–114, 2008; Nilsen, Trends Genet 23:243–249, 2007). Accumulating evidence has elucidated them as oncogenes or tumor suppressors in cancers such as hepatocellular carcinoma, breast cancer, and lung cancer (Liu et al., Gastroenterology 136:683–693, 2009; Yu et al., Cell 131:1109–1123, 2007; Zhou et al., Sci Rep 7:42680, 2017; Iorio and Croce, Carcinogenesis 33:1126–1133, 2012). MiRNAs are involved in various biological processes, including cell proliferation (Liu et al., Mol Cancer Res 11:1314–1325, 2013), differentiation (Liu et al., Mol Cancer Res 11:1314–1325, 2013), apoptosis (Pan et al., Oncol Res 24:429–435, 2016), invasion and metastasis (Liu et al., Nat Commun 8:14270, 2017). Understanding the role of miRNAs in tumor gives new perspective on cancer diagnosis and therapy (Rupaimoole and Slack, Nat Rev Drug Discov 16:203–222, 2017; Berindan-Neagoe et al., CA Cancer J Clin 64:311–336, 2014). This chapter will focus on the in vitro methods for identifying miRNAs roles in cell proliferation, invasion, and metastasis in tumor development, which includes CCK-8 assay, Wound Healing assay, and Transwell assay.

Key words

MiRNA Proliferation Invasion Metastasis 

Notes

Acknowledgment

This study was supported by the Key Laboratory of Laboratory Medicine of Jiangsu Province of China and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. We are grateful to the technical support from the National Key Clinical Department of Laboratory Medicine of Jiangsu Province Hospital.

References

  1. 1.
    Mo D, Yang D, Xiao X, Sun R, Huang L, Xu J (2017) MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin. Biotechnol Lett 39(5):701–710CrossRefPubMedGoogle Scholar
  2. 2.
    Liu K, Xie F, Gao A, Zhang R, Zhang L, Xiao Z, Hu Q, Huang W, Huang Q, Lin B et al (2017) SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis. Mol Cancer 16(1):62CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Zhou R, Zhou X, Yin Z, Guo J, Hu T, Jiang S, Liu L, Dong X, Zhang S, Wu G (2016) MicroRNA-574-5p promotes metastasis of non-small cell lung cancer by targeting PTPRU. Sci Rep 6:35714CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Jablonska-Trypuc A, Matejczyk M, Rosochacki S (2016) Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem 31(sup1):177–183CrossRefPubMedGoogle Scholar
  5. 5.
    Shields SE, Ogilvie DJ, McKinnell RG, Tarin D (1984) Degradation of basement membrane collagens by metalloproteases released by human, murine and amphibian tumours. J Pathol 143(3):193–197CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2018

Authors and Affiliations

  1. 1.Department of Laboratory MedicineThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina

Personalised recommendations